{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T23:07:46Z","timestamp":1774307266128,"version":"3.50.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,27]],"date-time":"2022-03-27T00:00:00Z","timestamp":1648339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,27]],"date-time":"2022-03-27T00:00:00Z","timestamp":1648339200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Genetic factors play an important role in susceptibility to hypertension. Herein, the association between acetaldehyde dehydrogenase 2 (ALDH2) and methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms and hypertension was analyzed among Hakka population in southern China.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A total of 3057 hypertensive patients and 2215 controls were enrolled. The <jats:italic>ALDH2<\/jats:italic> rs671 and <jats:italic>MTHFR<\/jats:italic> rs1801133 genotyping were analyzed using gene chip. Relevant information and medical records of these subjects were collected.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Hypertensive patients with <jats:italic>ALDH2<\/jats:italic> rs671 G\/A heterozygous had lower systolic blood pressure (SBP) than other genotypes (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001), while hypertensive patients with A allele had lower diastolic blood pressure (DBP) than patients with G allele (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). The level of plasma homocysteine (Hcy) in patients with <jats:italic>MTHFR<\/jats:italic> CC, CT and TT genotypes showed an increasing trend (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). The <jats:italic>ALDH2<\/jats:italic> G\/A genotype in the co-dominant model (adjusted OR 1.251, 95% CI 1.024\u20131.528, <jats:italic>P<\/jats:italic>\u2009=\u20090.028) and <jats:italic>ALDH2<\/jats:italic> A\/A genotype in the recessive model (adjusted OR 1.221, 95% CI 1.008\u20131.478, <jats:italic>P<\/jats:italic>\u2009=\u20090.041) were significant risk factors for the presence of hypertension. The <jats:italic>MTHFR<\/jats:italic> C\/T genotype in the co-dominant model (adjusted OR 1.307, 95% CI 1.039\u20131.643, <jats:italic>P<\/jats:italic>\u2009=\u20090.022) and <jats:italic>MTHFR<\/jats:italic> C\/T and T\/T genotypes in the dominant model (adjusted OR 1.281, 95% CI 1.146\u20131.430, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001) were significant risk factors for the presence of hypertension. Further, logistic regression analysis showed that age, smoking, alcohol consumption, hyperhomocysteinemia, and high level of serum TG, Apo-A1, Apo-B were significant risks for hypertension.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>In summary, <jats:italic>ALDH2<\/jats:italic> rs671 G\/A, A\/A genotypes and <jats:italic>MTHFR<\/jats:italic> rs1801133 C\/T, T\/T genotypes may be risk factors for hypertension in this Chinese Hakka population.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12872-022-02577-x","type":"journal-article","created":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T04:32:10Z","timestamp":1648528330000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Association of ALDH2 rs671 and MTHFR rs1801133 polymorphisms with hypertension among Hakka people in Southern China"],"prefix":"10.1186","volume":"22","author":[{"given":"Heming","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingyan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhikang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhixiong","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,27]]},"reference":[{"issue":"5","key":"2577_CR1","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.cvsm.2020.04.001","volume":"50","author":"RF Geddes","year":"2020","unstructured":"Geddes RF. Hypertension: why is it critical? The veterinary clinics of North America small animal practice. Vet Clin North Am Small Anim Pract. 2020;50(5):1037\u201352.","journal-title":"Vet Clin North Am Small Anim Pract"},{"issue":"2","key":"2577_CR2","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1001\/jama.2016.19043","volume":"317","author":"MH Forouzanfar","year":"2017","unstructured":"Forouzanfar MH, Liu P, Roth GA, et al. Global burden of hypertension and systolic blood pressure of at least 110 to 115 mm Hg, 1990\u20132015. JAMA. 2017;317(2):165\u201382.","journal-title":"JAMA"},{"issue":"14","key":"2577_CR3","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1136\/heartjnl-2014-305877","volume":"100","author":"AS Shah","year":"2014","unstructured":"Shah AS, Newby DE. Less clarity as the fog begins to lift. Heart. 2014;100(14):1073\u20134.","journal-title":"Heart"},{"issue":"5","key":"2577_CR4","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1001\/jama.2013.284427","volume":"311","author":"PA James","year":"2014","unstructured":"James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507\u201320.","journal-title":"JAMA"},{"issue":"6","key":"2577_CR5","first-page":"e13","volume":"71","author":"PK Whelton","year":"2018","unstructured":"Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71(6):e13\u2013115.","journal-title":"Hypertension"},{"issue":"10112","key":"2577_CR6","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1016\/S0140-6736(17)32478-9","volume":"390","author":"J Lu","year":"2017","unstructured":"Lu J, Lu Y, Wang X, et al. Prevalence, awareness, treatment, and control of hypertension in China: data from 1\u00b77 million adults in a population-based screening study (China PEACE Million Persons Project). Lancet. 2017;390(10112):2549\u201358.","journal-title":"Lancet"},{"issue":"10","key":"2577_CR7","first-page":"1780","volume":"42","author":"M Zhang","year":"2021","unstructured":"Zhang M, Wu J, Zhang X, et al. Prevalence and control of hypertension in adults in China, 2018. Chin J Epidemiol. 2021;42(10):1780\u20139.","journal-title":"Chin J Epidemiol"},{"issue":"8","key":"2577_CR8","doi-asserted-by":"publisher","first-page":"2567","DOI":"10.3390\/nu13082567","volume":"13","author":"D Di Raimondo","year":"2021","unstructured":"Di Raimondo D, Buscemi S. Ketogenic diet, physical activity, and hypertension\u2014a narrative review. Nutrients. 2021;13(8):2567.","journal-title":"Nutrients"},{"issue":"5323","key":"2577_CR9","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1136\/bmj.1.5323.75","volume":"1","author":"WE Miall","year":"1963","unstructured":"Miall WE, Oldham PD. The hereditary factor in arterial blood-pressure. Br Med J. 1963;1(5323):75\u201380.","journal-title":"Br Med J"},{"issue":"3","key":"2577_CR10","doi-asserted-by":"publisher","first-page":"268","DOI":"10.3109\/10641963.2015.1116543","volume":"38","author":"M Singh","year":"2016","unstructured":"Singh M, Singh AK, Pandey P, et al. Molecular genetics of essential hypertension. Clin Exp Hypertens. 2016;38(3):268\u201377.","journal-title":"Clin Exp Hypertens"},{"issue":"4","key":"2577_CR11","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s11920-019-1008-1","volume":"21","author":"HJ Edenberg","year":"2019","unstructured":"Edenberg HJ, Gelernter J, Agrawal A. Genetics of alcoholism. Curr Psychiatry Rep. 2019;21(4):26.","journal-title":"Curr Psychiatry Rep"},{"issue":"8","key":"2577_CR12","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1007\/s10038-003-0046-y","volume":"48","author":"I Ohsawa","year":"2003","unstructured":"Ohsawa I, Kamino K, Nagasaka K, et al. Genetic deficiency of a mitochondrial aldehyde dehydrogenase increases serum lipid peroxides in community-dwelling females. J Hum Genet. 2003;48(8):404\u20139.","journal-title":"J Hum Genet"},{"key":"2577_CR13","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.freeradbiomed.2018.05.085","volume":"125","author":"HY Small","year":"2018","unstructured":"Small HY, Migliarino S, Czesnikiewicz-Guzik M, Guzik TJ. Hypertension: focus on autoimmunity and oxidative stress. Free Radic Biol Med. 2018;125:104\u201315.","journal-title":"Free Radic Biol Med"},{"issue":"4","key":"2577_CR14","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1161\/HYPERTENSIONAHA.117.07802","volume":"70","author":"TJ Guzik","year":"2017","unstructured":"Guzik TJ, Touyz RM. Oxidative stress, inflammation, and vascular aging in hypertension. Hypertension. 2017;70(4):660\u20137.","journal-title":"Hypertension"},{"key":"2577_CR15","unstructured":"Huangfu W, Chang F, Wang M, Gao R. ALDH2 improved irbesartan treatment efficacy among rats with hypertension. Pak J Pharm Sci. 2019;32(5(Special)):2495\u20139."},{"key":"2577_CR16","doi-asserted-by":"publisher","first-page":"104133","DOI":"10.1016\/j.mvr.2021.104133","volume":"135","author":"B Roy","year":"2021","unstructured":"Roy B, Palaniyandi SS. A role for aldehyde dehydrogenase (ALDH) 2 in angiotensin II-mediated decrease in angiogenesis of coronary endothelial cells. Microvasc Res. 2021;135:104133.","journal-title":"Microvasc Res"},{"key":"2577_CR17","doi-asserted-by":"crossref","unstructured":"Zeng D, Huang Q, Yu Z, Wu H. Association between aldehyde dehydrogenase 2 gene rs671 G>A polymorphism and alcoholic liver cirrhosis in southern Chinese Hakka population. J Clin Lab Anal. 2021;35(7):e23855.","DOI":"10.1002\/jcla.23855"},{"issue":"12","key":"2577_CR18","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1111\/jch.13737","volume":"21","author":"L Fu","year":"2019","unstructured":"Fu L, Li YN, Luo D, et al. Evidence on the causal link between homocysteine and hypertension from a meta-analysis of 40 173 individuals implementing Mendelian randomization. J Clin Hypertens (Greenwich). 2019;21(12):1879\u201394.","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"2577_CR19","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.biochi.2020.02.012","volume":"173","author":"B Balint","year":"2020","unstructured":"Balint B, Jepchumba VK, Gu\u00e9ant JL, Gu\u00e9ant-Rodriguez RM. Mechanisms of homocysteine-induced damage to the endothelial, medial and adventitial layers of the arterial wall. Biochimie. 2020;173:100\u20136.","journal-title":"Biochimie"},{"key":"2577_CR20","doi-asserted-by":"crossref","unstructured":"Ornosa-Mart\u00edn G, Fernandez-Ballart JD, Ceruelo S, et al. Homocysteine, the methylenetetrahydrofolate reductase 677C>T polymorphism and hypertension: effect modifiers by lifestyle factors and population subgroups. Br J Nutr. 2020:1\u201311.","DOI":"10.1017\/S0007114520000793"},{"key":"2577_CR21","doi-asserted-by":"crossref","unstructured":"Yuyun MF, Ng LL, Ng GA. Endothelial dysfunction, endothelial nitric oxide bioavailability, tetrahydrobiopterin, and 5-methyltetrahydrofolate in cardiovascular disease. Where are we with therapy? Microvasc Res. 2018;119:7\u201312.","DOI":"10.1016\/j.mvr.2018.03.012"},{"issue":"12","key":"2577_CR22","doi-asserted-by":"publisher","first-page":"4562","DOI":"10.3390\/nu13124562","volume":"13","author":"S Raghubeer","year":"2021","unstructured":"Raghubeer S, Matsha TE. Methylenetetrahydrofolate (MTHFR), the one-carbon cycle, and cardiovascular risks. Nutrients. 2021;13(12):4562.","journal-title":"Nutrients"},{"key":"2577_CR23","doi-asserted-by":"publisher","first-page":"7311","DOI":"10.1038\/srep07311","volume":"4","author":"C Xuan","year":"2014","unstructured":"Xuan C, Li H, Zhao JX, et al. Association between MTHFR polymorphisms and congenital heart disease: a meta-analysis based on 9,329 cases and 15,076 controls. Sci Rep. 2014;4:7311.","journal-title":"Sci Rep"},{"key":"2577_CR24","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.ijcard.2017.12.026","volume":"254","author":"M Volpe","year":"2018","unstructured":"Volpe M, Gallo G, Tocci G. Is early and fast blood pressure control important in hypertension management? Int J Cardiol. 2018;254:328\u201332.","journal-title":"Int J Cardiol"},{"issue":"1","key":"2577_CR25","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.pop.2018.10.005","volume":"46","author":"P Perumareddi","year":"2019","unstructured":"Perumareddi P. Prevention of hypertension related to cardiovascular disease. Prim Care. 2019;46(1):27\u201339.","journal-title":"Prim Care"},{"issue":"2","key":"2577_CR26","doi-asserted-by":"publisher","first-page":"2750","DOI":"10.18632\/aging.202325","volume":"13","author":"P Long","year":"2020","unstructured":"Long P, He M, Yan W, et al. ALDH2 protects naturally aged mouse retina via inhibiting oxidative stress-related apoptosis and enhancing unfolded protein response in endoplasmic reticulum. Aging (Albany NY). 2020;13(2):2750\u201367.","journal-title":"Aging (Albany NY)"},{"issue":"4","key":"2577_CR27","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1291\/hypres.24.365","volume":"24","author":"S Takagi","year":"2001","unstructured":"Takagi S, Baba S, Iwai N, et al. The aldehyde dehydrogenase 2 gene is a risk factor for hypertension in Japanese but does not alter the sensitivity to pressor effects of alcohol: the Suita study. Hypertens Res. 2001;24(4):365\u201370.","journal-title":"Hypertens Res"},{"issue":"6","key":"2577_CR28","first-page":"6222","volume":"11","author":"L Zhang","year":"2018","unstructured":"Zhang L, Dong L, Qian M, Yang G. Association of ALDH2 rs671 polymorphism with essential hypertension: a case-control study in non-drinking Han Chinese. Int J Clin Exp Med. 2018;11(6):6222\u20137.","journal-title":"Int J Clin Exp Med"},{"issue":"1","key":"2577_CR29","doi-asserted-by":"publisher","first-page":"537","DOI":"10.4238\/vol10-1gmr1056","volume":"10","author":"T Hasi","year":"2011","unstructured":"Hasi T, Hao L, Yang L, Su XL. Acetaldehyde dehydrogenase 2 SNP rs671 and susceptibility to essential hypertension in Mongolians: a case control study. Genet Mol Res. 2011;10(1):537\u201343.","journal-title":"Genet Mol Res"},{"issue":"3","key":"2577_CR30","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/jhh.2012.15","volume":"27","author":"Y Wang","year":"2013","unstructured":"Wang Y, Zhang Y, Zhang J, et al. Association of a functional single-nucleotide polymorphism in the ALDH2 gene with essential hypertension depends on drinking behavior in a Chinese Han population. J Hum Hypertens. 2013;27(3):181\u20136.","journal-title":"J Hum Hypertens"},{"issue":"1","key":"2577_CR31","doi-asserted-by":"publisher","first-page":"11136","DOI":"10.1038\/s41598-017-11071-w","volume":"7","author":"C Ma","year":"2017","unstructured":"Ma C, Yu B, Zhang W, et al. Associations between aldehyde dehydrogenase 2 (ALDH2) rs671 genetic polymorphisms, lifestyles and hypertension risk in Chinese Han people. Sci Rep. 2017;7(1):11136.","journal-title":"Sci Rep"},{"key":"2577_CR32","doi-asserted-by":"crossref","unstructured":"Wu Y, Ni J, Cai X, et al. Positive association between ALDH2 rs671 polymorphism and essential hypertension: a case-control study and meta-analysis. PLoS ONE. 2017;12(5):e0177023.","DOI":"10.1371\/journal.pone.0177023"},{"key":"2577_CR33","first-page":"45","volume":"2","author":"J Feng","year":"2012","unstructured":"Feng J, Wang C, Qing YE, et al. Relationship between gene polymorphism of acetaldehyde dehydrogenase 2 and hypertension in aged patients. Chin J Cardiovasc Rehabil Med. 2012;2:45\u20138.","journal-title":"Chin J Cardiovasc Rehabil Med"},{"issue":"Suppl 9","key":"2577_CR34","first-page":"155","volume":"59","author":"H Jakubowski","year":"2008","unstructured":"Jakubowski H. The pathophysiological hypothesis of homocysteine thiolactone-mediated vascular disease. J Physiol Pharmacol. 2008;59(Suppl 9):155\u201367.","journal-title":"J Physiol Pharmacol"},{"key":"2577_CR35","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1475-2891-14-6","volume":"14","author":"P Ganguly","year":"2015","unstructured":"Ganguly P, Alam SF. Role of homocysteine in the development of cardiovascular disease. Nutr J. 2015;14:6.","journal-title":"Nutr J"},{"issue":"16","key":"2577_CR36","doi-asserted-by":"publisher","first-page":"2948","DOI":"10.2174\/0929867325666180313105949","volume":"26","author":"BL Zaric","year":"2019","unstructured":"Zaric BL, Obradovic M, Bajic V, et al. Homocysteine and Hyperhomocysteinaemia. Curr Med Chem. 2019;26(16):2948\u201361.","journal-title":"Curr Med Chem"},{"issue":"2","key":"2577_CR37","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/BF01875985","volume":"41","author":"H Nishio","year":"1996","unstructured":"Nishio H, Lee MJ, Fujii M, et al. A common mutation in methylenetetrahydrofolate reductase gene among the Japanese population. Jpn J Hum Genet. 1996;41(2):247\u201351.","journal-title":"Jpn J Hum Genet"},{"issue":"1","key":"2577_CR38","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1253\/circj.70.83","volume":"70","author":"H Lwin","year":"2006","unstructured":"Lwin H, Yokoyama T, Yoshiike N, et al. Polymorphism of methylenetetrahydrofolate reductase gene (C677T MTHFR) is not a confounding factor of the relationship between serum uric acid level and the prevalence of hypertension in Japanese men. Circ J. 2006;70(1):83\u20137.","journal-title":"Circ J"},{"issue":"3","key":"2577_CR39","first-page":"194","volume":"21","author":"S Zhan","year":"2000","unstructured":"Zhan S, Gao Y, Yin X, et al. A case-control study on the relationship between abnormal homocysteine metabolism and essential hypertension. Chin J Epidemiol. 2000;21(3):194\u20137.","journal-title":"Chin J Epidemiol"},{"issue":"7","key":"2577_CR40","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1007\/s00394-014-0659-2","volume":"53","author":"LL Husemoen","year":"2014","unstructured":"Husemoen LL, Skaaby T, J\u00f8rgensen T, et al. MTHFR C677T genotype and cardiovascular risk in a general population without mandatory folic acid fortification. Eur J Nutr. 2014;53(7):1549\u201359.","journal-title":"Eur J Nutr"},{"key":"2577_CR41","doi-asserted-by":"crossref","unstructured":"Fowdar JY, Lason MV, Szvetko AL, Lea RA, Griffiths LR. Investigation of homocysteine-pathway-related variants in essential hypertension. Int J Hypertens. 2012;2012:190923.","DOI":"10.1155\/2012\/190923"},{"issue":"7","key":"2577_CR42","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1080\/10641960802251958","volume":"30","author":"O Fridman","year":"2008","unstructured":"Fridman O, Porcile R, Vanasco V, et al. Study on homocysteine levels and methylenetetrahydrofolate reductase gene variant (C677T) in a population of Buenos Aires City. Clin Exp Hypertens. 2008;30(7):574\u201384.","journal-title":"Clin Exp Hypertens"},{"issue":"3","key":"2577_CR43","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3109\/10641963.2012.690471","volume":"35","author":"O Fridman","year":"2013","unstructured":"Fridman O, Porcile R, Morales AV, et al. Association of methylenetetrahydrofolate reductase gene 677C>T polymorphism with hypertension in older women in a population of Buenos Aires City. Clin Exp Hypertens. 2013;35(3):159\u201366.","journal-title":"Clin Exp Hypertens"},{"issue":"9","key":"2577_CR44","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1291\/hypres.27.663","volume":"27","author":"S Heux","year":"2004","unstructured":"Heux S, Morin F, Lea RA, et al. The methylentetrahydrofolate reductase gene variant (C677T) as a risk factor for essential hypertension in Caucasians. Hypertens Res. 2004;27(9):663\u20137.","journal-title":"Hypertens Res"},{"issue":"1","key":"2577_CR45","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1024\/0300-9831.78.1.33","volume":"78","author":"PT Lin","year":"2008","unstructured":"Lin PT, Cheng CH, Wei JC, Huang YC. Low plasma pyridoxal 5\u2019-phosphate concentration and MTHFR 677C\u2013>T genotypes are associated with increased risk of hypertension. Int J Vitam Nutr Res. 2008;78(1):33\u201340.","journal-title":"Int J Vitam Nutr Res"},{"issue":"6","key":"2577_CR46","doi-asserted-by":"publisher","first-page":"861","DOI":"10.3892\/br.2014.357","volume":"2","author":"W Cai","year":"2014","unstructured":"Cai W, Yin L, Yang F, Zhang L, Cheng J. Association between Hcy levels and the CBS844ins68 and MTHFR C677T polymorphisms with essential hypertension. Biomed Rep. 2014;2(6):861\u20138.","journal-title":"Biomed Rep"},{"issue":"1","key":"2577_CR47","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1089\/gtmb.2014.0213","volume":"19","author":"C Wen","year":"2015","unstructured":"Wen C, Lv JF, Wang L, et al. Association of a methylene tetrahydrofolate reductase C677T polymorphism with several blood chemical levels in a Chinese population. Genet Test Mol Biomark. 2015;19(1):24\u20139.","journal-title":"Genet Test Mol Biomark"},{"issue":"4","key":"2577_CR48","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1081\/CEH-120020391","volume":"25","author":"F Rodr\u00edguez-Esparrag\u00f3n","year":"2003","unstructured":"Rodr\u00edguez-Esparrag\u00f3n F, Hern\u00e1ndez-Perera O, Rodr\u00edguez-P\u00e9rez JC, et al. The effect of methylenetetrahydrofolate reductase C677T common variant on hypertensive risk is not solely explained by increased plasma homocysteine values. Clin Exp Hypertens. 2003;25(4):209\u201320.","journal-title":"Clin Exp Hypertens"},{"issue":"8","key":"2577_CR49","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1038\/ajh.2012.55","volume":"25","author":"RX Yin","year":"2012","unstructured":"Yin RX, Wu JZ, Liu WY, et al. Association of several lipid-related gene polymorphisms and blood pressure variation in the Bai Ku Yao population. Am J Hypertens. 2012;25(8):927\u201336.","journal-title":"Am J Hypertens"},{"issue":"Suppl 70","key":"2577_CR50","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/ajpa.23979","volume":"171","author":"TJ Benn","year":"2020","unstructured":"Benn TJ. Anthropological perspectives on genomic data, genetic ancestry, and race. Am J Phys Anthropol. 2020;171(Suppl 70):74\u201386.","journal-title":"Am J Phys Anthropol"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-022-02577-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-022-02577-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-022-02577-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,23]],"date-time":"2022-10-23T16:05:29Z","timestamp":1666541129000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-022-02577-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,27]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2577"],"URL":"https:\/\/doi.org\/10.1186\/s12872-022-02577-x","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,27]]},"assertion":[{"value":"3 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants were informed on the study procedures and goals and the study obtained written informed consent from all the participants. We confirm that all methods were performed in accordance with relevant guidelines and regulations. This study was approved by the Human Ethics Committees of Meizhou People's Hospital (Clearance No.: 2016-A-33).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"No pictures or information that could lead into the identification of the participants were included in this publication. All participants were informed on the scope with the study and the intention to publish the results while keeping personal information confident to the study team and all participants gave written consent to do so.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"We declare that the authors have no competing interests as defined by Journal of BMC Cardiovascular Disorders, or other interests that might be perceived to influence the results and\/or discussion reported in this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"128"}}